ITMCTR2100004596
Recruiting
Phase 4
Efficacy and safety of Qianlieshutong capsule in the treatment of type III prostatitis (TCM syndrome of damp-heat and blood-stasis obstruction): a multicenter, randomized, double-blind, single simulation, positive drug parallel controlled clinical trial
Beijing Hospital0 sitesTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Beijing Hospital
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. The diagnosis criterias of type III prostatitis are met;
- •2\. The diagnosis criterias of TCM syndrome of damp\-heat and blood\-stasis obstruction are met;
- •3\. Aged \>\= 18 and \<\= 50 years;
- •4\. Chronic prostatitis symptom index (NIH CPSI) is more than 10, and pain score was \>\= 4;
- •5\. Patients sign informed consent voluntarily.
Exclusion Criteria
- •1\. Patients have weak waist and knees and are afraid of cold;
- •2\. Patients diagnosed of benign prostatic hyperplasia, acute urinary retention, urethral stricture, epididymitis, seminal vesicle inflammation, severe neurosis, sexually transmitted diseases, bladder tumor, prostate cancer, and urinary male reproductive system tuberculosis;
- •3\. Patients with pain diseases of lower abdomen, perineum, lumbosacral and other parts caused by non prostatitis;
- •4\. Patients with severe cardiovascular, cerebrovascular, liver and kidney, endocrine system, hematopoietic system, mental and nervous system and other primary diseases, liver function ALT and / or AST were 1\.5 times higher than the upper limit of normal value, and renal function (CR) was greater than the upper limit of normal value;
- •5\. Suspected or confirmed history of alcohol and drug abuse;
- •6\. Urinary tract infection;
- •7\. Refractory patients treated with a \- blockers;
- •8\. Postural hypotension patients;
- •9\. Allergic to the trial drug and its components;
- •10\. Patients who had pelvic surgery within 3 months;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Efficacy and outcomes of Lian-Hua Qing-Wen capsule in the treatment of novel coronavirus pneumonia (COVID-19): a medical records based retrospective studyovel coronavirus disease (COVID-19)ITMCTR2000003537920th Hospital of the PLA Joint Logistics Support Force
Recruiting
Phase 1
Safety and efficacy of Huanshao capsule in the treatment of thin endometrium (Chong-Ren deficiency-cold syndrome): a self-controlled multicenter cohort studyThin endometriumITMCTR2100004367The Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Recruiting
Phase 4
Efficacy and safety of Wuling capsule in the treatment of early Parkinson's disease with mild depression: a multicenter, randomized, double-blind, placebo-controlled studyITMCTR2100004821Xinhua Hospital, Affiliated to Shanghai Jiaotong University, School of Medicine
Not yet recruiting
Phase 1
Efficacy and safety of Tongxinluo capsules combined with metoprolol tartrate in the treatment of angina pectoris in coronary heart disease: A study protocol of randomized, double-blind, placebo-controlled clinical trialTCTR20220505005Pengcheng Ren114
Not yet recruiting
Phase 4
A clinical study of Quanduzhong capsule in treating primary osteoporosis (kidney-yang deficiency syndrome)ITMCTR2100005285Wangjing Hospital of China Academy of Chinese Medical Sciences